Article By:
ChinaBio® Today
Saturday, September 3, 2022 3:51 PM EDT
Beijing Biocytogen Pharma completed a $60 million IPO on the Hong Kong Exchange for its genetically modified animal and cell model business, which it offers to pharmaceutical/biotech companies. Biocytogen has a market capitalization of $357 million.